| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 1863-1868, Copyright © 1994 by Endocrine Society
ARTICLES |
CM Boney, BM Moats-Staats, AD Stiles and AJ D'Ercole
Department of Pediatrics, University of North Carolina, Chapel Hill 27599-7220.
Insulin-like growth factor-I (IGF-I) stimulates the differentiation of preadipocytes, but the expression of IGF-I and IGF-binding proteins (IGFBPs) during the course of adipogenesis has not been investigated. Using two in vitro models, primary mouse preadipocytes and the 3T3-L1 preadipocyte cell line stimulated to differentiate with IGF-I, we studied IGF and IGFBP expression before and during differentiation. Primary preadipocyte cultures expressed IGF-I, IGFBP-2, and IGFBP-4 messenger RNAs (mRNAs), and conditioned medium (CM) contained IGFBP-3 [approximately 46,000 mol wt (M(r))], IGFBP-4 (24,000 M(r)), and a 30,000 M(r) IGFBP identified by immunoblot as IGFBP-2. During differentiation, an additional approximately 34,000 M(r) form of IGFBP- 2 was predominant, but IGFBP-2 mRNA decreased, suggesting that a mechanism other than steady state mRNA levels is regulating protein abundance in CM. Like primary cultures, undifferentiated 3T3-L1 cells expressed IGFBP-4 mRNA, but insignificant levels of IGF-I and IGFBP-2 mRNAs. 3T3-L1 cell CM contained IGFBP-3 and IGFBP-4, and with the addition of IGF-I, a 30,000 M(r) IGFBP was also present. This IGFBP was not recognized by antiserum to IGFBP-1, -2, -4, -5, or -6. During differentiation of 3T3-L1 cells, an approximately 34,000 M(r) form of IGFBP-2 was also present in CM. In summary, primary cultures of mouse preadipocytes and 3T3-L1 cells express similar IGFBPs during IGF-I- stimulated adipogenesis. The presence of a larger isoform of IGFBP-2 in a differentiation-dependent manner and a potentially novel IGFBP in response to IGF-I suggests that these IGFBPs may be important in modulating IGF-I action in adipogenesis.
This article has been cited by other articles:
![]() |
S. B. Wheatcroft, M. T. Kearney, A. M. Shah, V. A. Ezzat, J. R. Miell, M. Modo, S. C.R. Williams, W. P. Cawthorn, G. Medina-Gomez, A. Vidal-Puig, et al. IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance Diabetes, February 1, 2007; 56(2): 285 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Y. Chan, S. M. Twigg, S. M. Firth, and R. C. Baxter Insulin-Like Growth Factor Binding Protein-3 Leads to Insulin Resistance in Adipocytes J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6588 - 6595. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, J. Nohr, C. H. Jensen, R. K. Petersen, E. Bachmann, B. Teisner, L. K. Larsen, S. Mandrup, and K. Kristiansen Insulin-like Growth Factor-1/Insulin Bypasses Pref-1/FA1-mediated Inhibition of Adipocyte Differentiation J. Biol. Chem., May 30, 2003; 278(23): 20906 - 20914. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. GREGOIRE, C. M. SMAS, and H. S. SUL Understanding Adipocyte Differentiation Physiol Rev, July 1, 1998; 78(3): 783 - 809. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |